Renal siderosis in donor allograft: Pathologic and clinical sequelae

American Journal of Transplantation

Volumn 4, Issue 10, 2004, Pages 1717-1719

  Salim, Sadia ^a   Asada, Haider ^a   Kumar, Mysore S Anil ^a   Brezin, Joseph ^a   Heifets, Michael ^a   Fyfe, Billie ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Donor allograft; Marginal donor organ; Renal siderosis

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

AGED; ALLOGRAFT; ARTICLE; CADAVER KIDNEY; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; PRIORITY JOURNAL; REMISSION; RENAL SIDEROSIS; SIDEROSIS; SYMPTOM; TREATMENT OUTCOME;

AGED; FEMALE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SIDEROSIS; TRANSPLANTS;

EID: 4744362091     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00555.x     Document Type: Article

References (19)

1. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-23.
2. Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with hemachromotosis. J Pathol Bacteriol 1962; 84: 53-64.
3. First MR. Expanding the donor pool. Sem Nephrol 1997; 17: 373.
4. United Network for Organ Sharing. UNOS Scientific Registry data, 10/28/2002.
5. Xue JL, Ma JZ, Louis TA et al. Forecast of the number of patients with end stage renal disease in the united states to the year 2010. J Am Soc Nephr 2001; 12: 27.
6. Shaheen FA, Sheikh IA, Awad A et al. Use of marginal donors in kidney transplantation. Transplant Proc 2002; 34: 2454-2455.
7. Randhawa P. Role of donor kidney biopsies in renal transplantation. Transplantation 2001; 71: 1361-1365.
8. Rosengard BR, Feng S, Alfrey EJ et al. Report of the Crystal City meeting to maximize the use of organ recovered from the cadaver donor. Am J Transplant 2002; 2: 1-10.
9. Fahr T. Pathologische Anatomie des Morbus Brightii. In: Henke F, Lubarsch O (eds). Handbuch der Speziellen Pathologischen Anatomie und Histologie. Berlin: Springer, 1925; 6: 156. [PMID 7155980]
10. Althoff H. [Massive renal hemosiderosis in Marchiafava anemia and the possibility of an in-vitro desferrization through desferriofamine B]. Gegenbaurs Morphologisches Jahrbuch 1967; 111: 292-300. [In German]
11. Koliakos G, Papachristou F, Koussi A, Perifanis V, Tsatra I, Souliou E. Urine biochemical markers of early renal dysfunction are associated with iron overload in beta-thalassaemia. Clin Lab Haematol 2003; 25: 105-109.
12. Pardo-Mindan FJ, Diez J, Esparza N, Robledo C. Renal siderosis in patients with heart-valve prostheses: clinical implications. Nephrol Dial Transplant 1990; 5: 847-850.
13. Toszegi A, Boti Z, Kovacs G. Renal siderosis in cardiac intravassal hemolysis. Morphol Igazsagugyi Orv Sz 1981; 21: 224-231.
14. Zager RA, Foerder CA. Effects of inorganic iron and myoglobin on in-vitro proximal tubular lipid peroxidation and cytotoxicity. J Clin Invest 1992; 89: 989-995.
15. Nankivell BJ, Boadle RA, Harris DC. Iron accumulation in human chronic renal disease. Am J Kidney Dis 1992; 20: 580-584.
16. Nath KA, Balla G, Vercelloti GM et al. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 1992; 90: 267-270.
17. Paller MS, Hedlund BE. Role of iron in postischemic renal injury in the rat. Kidney Int 1988; 34: 474-80.
18. Salahudeen A, Nawaz M, Poovala V et al. Cold storage induces time-dependent F2-isoprostane formation in renal tubular cells and rat kidneys. Kidney Int 1999; 55: 1759.
19. Huang H, He Z, Roberts IILJ, Salahudeen AK. Deferoxamine reduces cold-ischemic renal injury in a syngeneic kidney transplant model. Am J Transplant 2003; 3: 1531.